期刊文献+

透明质酸钠联合复方倍他米松关节腔注射治疗类风湿关节炎 被引量:6

Effect of intraarticular injection of hyaluronate sodium and compound betamethasone in treatment of rheumatoid arthritis
暂未订购
导出
摘要 目的探讨联合使用透明质酸钠和复方倍他米松关节腔注射治疗类风湿关节炎的疗效。方法 64例类风湿关节炎患者随机分为两组,联合组32例,在第1周采用透明质酸钠2ml和复方倍他米松1ml进行膝关节腔内注射,以后4周则单独注射透明质酸钠2ml,每周1次。对照组32例,膝关节腔内注入透明质酸钠2ml,每周1次,连续5周。两组均随访3个月。结果用药5周后至停药后3个月,联合组总有效率为90.63%,对照组总有效率为78.13%,两组疗效差异有统计学意义(P<0.05)。结论透明质酸钠和复方倍他米松联用与单用透明质酸钠治疗类风湿关节炎均有疗效,但前者治疗效果更优。 Objective To discuss the rapeutic effect of intraarticular injection of hyaluronate sodium andcompound betamethasone in treatment of rheumatoid arthritis.Methods 64 cases of rheumatoid arthritis were randomly divided into two groups,including 32 cases in combined treatment group,who were injected intraarticularly both 2 ml hyaluronate sodium and 1 ml compound betamethasone at the first week,but only 2 ml hyaluronate sodium was injected,once a week in the following four weeks and 32 cases in control group,who were treated with 2ml hyaluronate sodium once a week for 5 consecutive weeks.The two groups were followed up for 3 months.Results The overall effective rate were 90.63% and 78.13% in the combined treatment group and the control group respectively,5 weeks after administration and 3 months after withdrawal.There was statistical difference between groups in the treatment outcome(P&lt;0.05).Conclusion The combination of hyaluronate sodium and compound betamethasone and hyaluronate sodium alone for the treatment of rheumatoid arthritis can present effectiveness but the former is superior to the latter.
作者 陆璧 程秀峰
出处 《中国当代医药》 2013年第23期89-90,共2页 China Modern Medicine
关键词 透明质酸钠 复方倍他米松 关节腔内注射 类风湿关节炎 Hyaluronate sodium Compound betamethasone Intraarticular injection Rheumatoid arthritis
  • 相关文献

参考文献12

  • 1Alex P, Szodoray P, Arthur E, et al.Influence of intraarticular corticos- teroid administration on serum cytokines in rheumatoid arthritis [J]. Clin Rheumatol, 2007,26 (5) : 845-848.
  • 2Makrygiannakis D,af Klint E,Catrina SB,et al.lntraarticular corticos- teroids decrease synovial RANKL expression in inflammatory arthritis[J]. Arthritis Rheum, 2006,54 ( 5 ) : 1463- i 472.
  • 3Furtado RN,Oliveira LM,Natour J.Polyarticular corticosteroid injec- tion versus systemic administration in treatment of rheumatoid arthri- tis patients : a randomized controlled study [J].J Rheumatol,2005,32 (9) : 1691-1698.
  • 4程秀峰,谭魁麟.透明质酸钠治疗老年类风湿关节炎临床研究[J].实用老年医学,2002,16(4):199-200. 被引量:2
  • 5van der Heijde DM.Joint erosions and patients with early rheumatoid arthritis[J].Br J Rheumatol, 1995,34 (Suppl 2 ) : 74-78.
  • 6Turesson C,O'Fallon WM, Crowson CS,et al. Occurrence of extraar- ticular disease manifestation is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis [J].J Rheumatol, 2002,29 ( 1 ) : 62-67.
  • 7O'Dell JR.Treating rheumatoid arthritis early:A window of opportuni- ty[J].Arthritis Rheum, 2002,46 (2) : 283-285.
  • 8徐华,赵洪涛,王玉霞,王钱,黄慈波.局部关节腔注射激素治疗类风湿关节炎的临床研究[J].中国老年学杂志,2007,27(7):682-684. 被引量:5
  • 9潘解萍,吴敏,马英淳,孙茹蓉.类风湿关节炎患者血清软骨寡聚基质蛋白水平及意义的研究[J].中华风湿病学杂志,2008,12(9):610-612. 被引量:9
  • 10Weitoft T,Larsson A,Saxne T,et al.Changes of cartilage and bone markers after intraarticular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis[J].Ann Rheum Dis, 2005,64 (12) : 1750-1753.

二级参考文献29

  • 1凌沛学 贺艳丽 郭学平 等.透明质酸[M].北京:中国轻工业出版社,2002.137-144.
  • 2Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein: a predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol, 2003, 32: 156-161.
  • 3董怡.类风湿关节炎//叶任高.内科学.6版.北京:人民卫生出版社,2006:885-891.
  • 4Marti C, Neidhart M, Gerber T, et al. Cartilage oligomeric matrix protein: the role of a non-collagen cartilage matrix proteinas a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis. Zeitschrift fur Rheumatologie, 1999, 58: 79-87.
  • 5Crukic M, Mansson B, Larsson L. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther, 2003, 5: 181-185.
  • 6Larsson E, Erlandsson-Harris H, Larsson A, et al. Cortieosternid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatol, 2004, 43: 428-434.
  • 7Momohara S, Yamanaka-H, Holledge MM, et al. Cartilage oligomeric matrix protein in serum and syuovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage. Mod Rheumatol, 2004, 14: 356-360.
  • 8Gomez-Barrena E, Lindroos L, Ceponis A, et al. Cartilage oligomerie matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis. Clin Exp Rheumatol, 2006, 24: 622-628.
  • 9Wislowska M, Jablonska B. Serum cartilage ohgomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis. Clin Rheumatol, 2005, 24: 278-284.
  • 10Skoumal M, Haberhauer G, Fevertag J, et al. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment. Rheumatol Int, 2006, 26: 1001-1004.

共引文献20

同被引文献59

  • 1吴建红,杨丽华,桂明星,李和柏.复方倍他米松联合透明质酸钠治疗膝骨关节炎60例[J].中国药业,2004,13(12):69-69. 被引量:5
  • 2查青林,何羿婷,卢毓雄,喻建平,闫小萍,苏励,宋跃进,曾升平,刘维,冯兴华,钱先,朱婉华,吕爱平.血小板数量与中西医治疗类风湿关节炎疗效关系的探讨[J].中国中西医结合杂志,2007,27(1):29-32. 被引量:10
  • 3单丽娟,周铭心,吕光耀.论西北燥证中燥邪与湿邪的病机转化[J].新疆医科大学学报,2007,30(1):20-22. 被引量:23
  • 4姜泉,蒋红,曹炜,焦娟.475例类风湿关节炎患者中医临床证候分析[J].中医杂志,2007,48(3):253-255. 被引量:147
  • 5Sizova LV,Baqirova GG,Chernysheva TV.Comparative analysis of ef-fectiveness and safely of diclofenac and nimesulide in patients withearly rheumatoid arthritis[J].Klin Med,2012,87(10):62-66.
  • 6Turesson C,(VFallon WM,Crowson CS,et al.Occurrence of extraar-ticular disease manifestation is associated with excess mortality in acommunity based cohort of patients with rheumatoid arthritis[J].JRheumatol,2012,29(1):62-67.
  • 7Lee YRfJin GH,Lee SM’et al.Inhibition of TNF-a mediated in-flammatory responses by a benzodioxolylacetylamino-linked benzothi-azole analog in human fibroblast-like synoviocytes[J].Biochem Bio-phys Res Commun,2011,408(4):625-629.
  • 8Alex P,Szodoray P,Arthur E,et al.Influence of intraarticular cortico-steroid administration on serum cytokines in rheumatoid arthritis[J].Clin Rheumatol,2011,26(5):845-848.
  • 9Gonzalez MA,Gonzalez C,Martin J.Rheumatoid arthritis:a disease as-sociated with accelerated atherogenesis[J].Semin Arthtitis Rheum,2012,35(1):8-17.
  • 10Prevoo ML,van't Hof MA,Kuper HH, et al. Modified dis- ease activity scores that include twenty-eight- joint counts. Development and validation in a pro- spective longitudinal study of patients with rheu- matoid arthritis[J]. Arthritis Rheum, 1995,38(1):44- 48.

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部